Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease

Lancet

Volumn 355, Issue 9214, 2000, Pages 1518-1519

  Fasano, Alessio ^a   Not, Tarcisio ^b   Wang, Wenle ^a   Uzzau, Sergio ^a   Berti, Irene ^a   Tommasini, Alberto ^b   Goldblum, Simeon E ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

UNCLASSIFIED DRUG; ZONULIN;

ADULT; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CELIAC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ACTIVITY; FETUS; HUMAN; HUMAN TISSUE; INTESTINE MUCOSA PERMEABILITY; MAJOR CLINICAL STUDY; NONHUMAN; NORMAL HUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; RAT; RHESUS MONKEY; TIGHT JUNCTION;

EID: 0034728821     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)02169-3     Document Type: Article

References (5)

1. Fasano A., Uzzau S., Fiore C., Margaretten K. The enterotoxic effect of zonula occludens toxin (Zot) on rabbit small intestine involves the paracellular pathway. Gastroenterology. 112:1997;839-846.
2. Larkin M. Out with the jab, in with painless pills. Lancet. 349:1997;1676.
3. Schulzke J.D., Bentzel C.J., Schulzke I., Riecken E.O., Fromm M. Epithelial tight junction structure in the jejunum of children with acute and treated celiac sprue. Pediatr Res. 43:1998;435-441.
4. Ventura A., Magazzu G., Greco L. Duration of exposure to gluten and risk for autoimmune disorders in celiac patients. Gastroenterology. 117:1999;303-310.
5. Meddings J.B., Jarand J., Urbanski S.J., Hardin J., Gall D.G. Increased gastrointestinal permeability is an early lesion in the spontaneously diabetic BB rat. Am J Physiol. 276:1999;G951-957.